Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Join NJ ACTS Workforce Core for Python Training on June 20th or June 22nd!
- Heather Howard Princeton Pulse Podcast – “Why Millions of Americans May Lose Their Health Insurance Coverage”
- New NJACTS Publication
- Join NJ ACTS for NIH Grant Bootcamp on July 11th!
- Senior Internships with Rutgers Innovation Ventures – Apply Now!